58 results
6-K
EX-99.1
PRE
Prenetics Global Limited - Ordinary Shares
1 Apr 24
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
7:38am
foresee vast opportunities within the consumer healthcare sector and look forward to sharing more about our strategic initiatives in due course … management team and potentially large opportunities in consumer healthcare, we are poised to build on our momentum and delivering long-term value to our
424B3
PRE
Prenetics Global Limited - Ordinary Shares
16 Feb 24
Prospectus supplement
6:13am
. Founded in 2014 from a vision to redefine the very essence of healthcare, we harness the unparalleled power of genomics to pioneer the future … commitment is to empower every individual with transformative, personalized healthcare journeys. Through relentless dedication to groundbreaking
F-3
PRE
Prenetics Global Limited - Ordinary Shares
17 Jan 24
Shelf registration (foreign)
6:59am
essence of healthcare, we harness the unparalleled power of genomics to pioneer the future of prevention, early cancer detection, and precision … with transformative, personalized healthcare journeys. Through relentless dedication to groundbreaking research, cutting-edge technology, and real-world
424B3
PRE
Prenetics Global Limited - Ordinary Shares
2 Nov 23
Prospectus supplement
4:04pm
and treatment of cancer. Founded in 2014 from a vision to redefine the very essence of healthcare, we harness the unparalleled power of genomics … foundation of longevity. Our commitment is to empower every individual with transformative, personalized healthcare journeys. Through relentless dedication
POS AM
PRE
Prenetics Global Limited - Ordinary Shares
6 Oct 23
Prospectus update (post-effective amendment)
1:52pm
in 2014 from a vision to redefine the very essence of healthcare, we harness the unparalleled power of genomics to pioneer the future of prevention, early … is to empower every individual with transformative, personalized healthcare journeys. Through relentless dedication to groundbreaking research
F-3
0iv2v8iv oinukwufu
29 Sep 23
Shelf registration (foreign)
9:17am
424B3
kjc0232qerl6zxsmy
21 Jul 23
Prospectus supplement
6:16am
POS AM
ehm6q
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
6-K
EX-99.1
die1vh3ds95
26 Jun 23
Current report (foreign)
8:45am
6-K
EX-99.1
hyy9l8xz25wqh
5 Jun 23
Prenetics Announces First Quarter 2023 Financial Results
7:18am
POS AM
uvrjidqgx 8rvp7ic1
31 May 23
Prospectus update (post-effective amendment)
8:25am
POS AM
m1ltyb3rl4c8
1 May 23
Prospectus update (post-effective amendment)
5:19pm
6-K/A
EX-99.1
116ukpd
1 May 23
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
4:03pm
6-K
EX-99.1
el6ice
16 Dec 22
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
8:06am
POS AM
hiou9to7drz6pmz
14 Dec 22
Prospectus update (post-effective amendment)
8:04am
POS AM
EX-21.1
8yjx7jn36fa4 51nq
14 Dec 22
Prospectus update (post-effective amendment)
8:04am